Spontaneous hypothyroidism in the follow up of graves hyperthyroid patients treated with antithyroid drugs

Southern Medical Journal

Volumn 99, Issue 10, 2006, Pages 1068-1072

  De Moraes, Adriana V C ^a   Pedro, Ana Beatriz P ^a   Romaldini, João H ^a,b  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Antithyroid drugs; Graves disease; Hypothyroidism; Thyroid antibodies; Thyroiditis

Indexed keywords

ANTITHYROID AGENT; LIOTHYRONINE; PEROXIDASE; PROPYLTHIOURACIL; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; REMISSION;

ADOLESCENT; ADULT; AGED; ANTITHYROID AGENTS; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; THYROGLOBULIN; THYROTROPIN; THYROXINE; TIME FACTORS;

EID: 33750297447     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000240120.89381.b2     Document Type: Article

References (34)

1. Fisfalen ME, Palmer EM, Van Seventer GA, et al. Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. J Clin Endocrinol Metab 1997;82:3655-3663.
2. Lesho E, Jones RE. Hypothyroid Graves' disease. South Med J 1997;90:1201-1203.
3. Irvine WJ, Gray RS, Toft AD, et al. Spectrum of thyroid function in patients remaining in remission after antithyroid drug therapy for thyrotoxicosis. Lancet 1977;2:179-181.
4. Wood LC, Ingbar SH. Hypothyroidism as a late sequela in patients with Graves' disease treated with antithyroid agents. J Clin Invest 1979;64:1429-1436.
5. Van Welsum M, Feltkam TE, De Vries MJ, et al. Hypothyroidism after thyroidectomy for Graves' disease: a search for an explanation. Br Med J 1974;4:755-756.
6. Reid DJ. Hyperthyroidism and hypothyroidism complicating the treatment of tyrotoxicosis. Br J Surg 1987;74:1060-1062.
7. Hallengren B, Forsgren A, Melander A. Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab 1980;2:298-301.
8. McGregor AM, Petersen MM, McLachan SM, et al. Carbimazole and the autoimmune response in Graves' disease. N Engl J Med 1980;303:302-307.
9. Weetman AP. Graves' disease. N Engl J Med 2000;343:1236-1248.
10. Lamberg BA, Salmi J, Wagar G, et al. Spontaneous hypothyroidism after antithyroid treatment of hyperthyroid Graves' disease. J Endocrinol Invest 1981;4:399-402.
11. Leary AC, Grealy G, Higgens TM, et al. Long-term outcomes of treatment of hyperthyroidism in Ireland. Ir J Med Sci 1999;168:47-52.
12. Tamai H, Kasagi K, Takaishi Y, et al. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroid drugs: clinical, immunological and histological findings in 26 patients. J Clin Endocrinol Metab 1989;69:49-53.
13. Wayne E. The assessment of thyroid function. Br J Surg 1965;52:717-721.
14. Sgarbi JA, Villaça FG, Garbeline B, et al. The effects of early antithyroid therapy for endogenous subclinical hyperthyroid in clinical and heart abnormalities. J Clin Endocrinol Metab 2003;88:1672-1677.
15. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the committee of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 1977;44:203-204.
16. Escobar-Jimenez F, Fernadez-Soto ML, Luna-Lopes V, et al. Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years. Postgrad Med J 2000;76:340-344.
17. Romaldini JH, Bromberg N, Werner RS, et al. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. J Clin Endocrinol Metab 1983;57:563-570.
18. Werner RS, Romaldini JH, Farah CS, et al. Serum thyroid stimulating antibody, thyroglobulin levels and thyroid suppressibility measurement as predicted of outcome of combined methimazole and triiodothyronine therapy in Graves' disease. Thyroid 1991;1:293-299.
19. Tamai H, Hirota Y, Kasagi K, et al. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment. J Clin Endocrinol Metab 1987;64:718-722.
20. Shiguemasa C, Mitani Y, Tanigushi S, et al. Development of post partum spontaneously resolving transient Graves' hyperthyroidism followed immediately by transient hypothyroidism. J Intern Med 1990;228:23-28.
21. Tamai H, Kasagi K, Hara T, et al. Follow-up study of thyroid stimulating blocking antibodies in hypothyroid patients. Clin Endocrinol 1990;33:699-707.
22. Buchanan WW, Koutras DA, Crooks J, et al. The clinical significance of the complement fixation test in thyrotoxicosis. J Endocrinol 1962;24:115-125.
23. Fatourechi V, McConahey WM, Woolner LB. Hyperthyroidism associated with histological Hashimoto's thyrotoxicosis. Mayo Clin Proc 1971;46:682-689.
24. Hirota Y, Tamai H, Hayashi Y, et al. Thyroid function and histology in forty-five patients with hyperthyroid Graves"disease in clinical remission more then 10 years after thionamide drug treatment. J Clin Endocrinol Metab 1986;62:165-169.
25. Paschke R, Vogg M, Swillens S, et al. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease. J Clin Endocrinol Metab 1993;77:939-943.
26. Mariotti S, Caturegli P, Piccolo P, et al. Antithyroid peroxidase antibodies in thyroid disease. J Clin Endocrinol Metab 1990;71:661-669.
27. Prentice LM, Phillips DI, Sarsero D, et al. Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol (Copenh) 1990;123:493-498.
28. Palmer KT. A prospective study into thyroid disease in a geriatric unit. N Z Med J 1977;86:323-324.
29. Chueire VB, Silva ET, Perrotta E, et al. High serum TSH levels are associated with depression in the elderly. Arch Gerontol Geriatr 2003;36:281-288.
30. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Wickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68.
31. Hollowell JG, Staehlyng NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-499.
32. Kraiem Z, Baron E, Kahana L, et al. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing tree cycles of transition from hypo to hyperthyroidism and back to hypothyroidism. Clin Endocrinol (Oxf) 1992;36:211-214.
33. Ueta Y, Fukui H, Murakami H, et al. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy. Thyroid 1999;2:179-182.
34. Chiovato L, Marcocci C, Mariotti S, et al. L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibody in idiopathic mixedema and in hypothyroid but not in euthyroid Hashimotós thyroiditis. J Endocrinol Invest 1986;9:299-305.